rct
    2011

    Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances

    Cases J, Ibarra A, Feuillere N

    Published in Mediterranean Journal of Nutrition and Metabolism

    Key Findings

    A standardised Melissa extract reduced anxiety manifestations by 18% and insomnia by 42% over 15 days in an open pilot.

    Conclusions

    Preliminary support for anxiety and sleep benefit.

    Limitations

    Open-label, no placebo control, tiny sample.

    Supplements Studied

    Anxiety manifestations decreased by 18% and insomnia by 42% after 15 days of a standardised Melissa officinalis extract.

    Related Health Concerns

    Insomnia
    Anxiety

    Study Details

    Year:2011
    Sample Size:20
    Duration:2 weeks
    Quality Score:4/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.